Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-05

Clinical Trial Update: Prospective Double-Blind Randomized Controlled Clinical Trial in the Gingivitis Prevention With OPCs [Phase 4]

View source ↗

Summary

A completed Phase 4, double-blind randomized trial evaluating gingivitis prevention with oligomeric proanthocyanidins (OPCs).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPCs (oligomeric proanthocyanidins)

Snippet

Sponsor: University of Seville | Conditions: Gingivitis | Phase 4 | Status: COMPLETED